115 related articles for article (PubMed ID: 37682095)
21. Cerebral small vessel disease affects white matter microstructure in mild cognitive impairment.
Papma JM; de Groot M; de Koning I; Mattace-Raso FU; van der Lugt A; Vernooij MW; Niessen WJ; van Swieten JC; Koudstaal PJ; Prins ND; Smits M
Hum Brain Mapp; 2014 Jun; 35(6):2836-51. PubMed ID: 24115179
[TBL] [Abstract][Full Text] [Related]
22. Structural changes in the lobar regions of brain in cerebral small-vessel disease patients with and without cognitive impairment: An MRI-based study with automated brain volumetry.
Liu C; Zhao L; Yang S; Luo Y; Zhu W; Zhu W; Shi L
Eur J Radiol; 2020 May; 126():108967. PubMed ID: 32268244
[TBL] [Abstract][Full Text] [Related]
23. Transport of L-arginine and the nitric oxide inhibitor NG-monomethyl-L-arginine in human erythrocytes in chronic renal failure.
Mendes Ribeiro AC; Hanssen H; Kiessling K; Roberts NB; Mann GE; Ellory JC
Clin Sci (Lond); 1997 Jul; 93(1):57-64. PubMed ID: 9279204
[TBL] [Abstract][Full Text] [Related]
24. Effect of Obstructive Sleep Apnea and CPAP Treatment on the Bioavailability of Erythrocyte and Plasma Nitric Oxide.
Mochol J; Gawryś J; Szahidewicz-Krupska E; Wiśniewski J; Fortuna P; Rola P; Martynowicz H; Doroszko A
Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429438
[TBL] [Abstract][Full Text] [Related]
25. Cerebral Microbleeds Are Associated With Increased Brain Iron and Cognitive Impairment in Patients With Cerebral Small Vessel Disease: A Quantitative Susceptibility Mapping Study.
Li J; Nguyen TD; Zhang Q; Guo L; Wang Y
J Magn Reson Imaging; 2022 Sep; 56(3):904-914. PubMed ID: 35099829
[TBL] [Abstract][Full Text] [Related]
26. Plasma brain natriuretic peptide is a biomarker for screening ischemic cerebral small vessel disease in patients with hypertension.
Wei W; Chen Y; Lei D; Zhang Y; Weng X; Zhou Y; Zhang L
Medicine (Baltimore); 2018 Aug; 97(35):e12088. PubMed ID: 30170428
[TBL] [Abstract][Full Text] [Related]
27. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension.
Panza JA; Casino PR; Badar DM; Quyyumi AA
Circulation; 1993 May; 87(5):1475-81. PubMed ID: 8491002
[TBL] [Abstract][Full Text] [Related]
28. The transporter and permeability interactions of asymmetric dimethylarginine (ADMA) and L-arginine with the human blood-brain barrier in vitro.
Watson CP; Pazarentzos E; Fidanboylu M; Padilla B; Brown R; Thomas SA
Brain Res; 2016 Oct; 1648(Pt A):232-242. PubMed ID: 27431938
[TBL] [Abstract][Full Text] [Related]
29. Heterogeneity of White Matter Hyperintensities in Cognitively Impaired Patients With Cerebral Small Vessel Disease.
Wang T; Jin A; Fu Y; Zhang Z; Li S; Wang D; Wang Y
Front Immunol; 2021; 12():803504. PubMed ID: 34956241
[TBL] [Abstract][Full Text] [Related]
30. l-Citrulline restores nitric oxide level and cellular uptake at the brain capillary endothelial cell line (TR-BBB cells) with glutamate cytotoxicity.
Lee KE; Kang YS
Microvasc Res; 2018 Nov; 120():29-35. PubMed ID: 29870781
[TBL] [Abstract][Full Text] [Related]
31. Homocysteine is Associated with the Development of Cerebral Small Vessel Disease: Retrospective Analyses from Neuroimaging and Cognitive Outcomes.
Ji Y; Li X; Teng Z; Li X; Jin W; Lv PY
J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105393. PubMed ID: 33254368
[TBL] [Abstract][Full Text] [Related]
32. YKL-40 as a novel biomarker related to white matter damage and cognitive impairment in patients with cerebral small vessel disease.
Zhang W; Zhou X; Yin J; Zhao W; Huang C; Zhang C; Wan K; Li M; Zhu X; Sun Z
Brain Res; 2023 May; 1807():148318. PubMed ID: 36898474
[TBL] [Abstract][Full Text] [Related]
33. Cilostazol reduces blood brain barrier dysfunction, white matter lesion formation and motor deficits following chronic cerebral hypoperfusion.
Edrissi H; Schock SC; Cadonic R; Hakim AM; Thompson CS
Brain Res; 2016 Sep; 1646():494-503. PubMed ID: 27350079
[TBL] [Abstract][Full Text] [Related]
34. Perfusion heterogeneity of cerebral small vessel disease revealed via arterial spin labeling MRI and machine learning.
Lu W; Yu C; Wang L; Wang F; Qiu J
Neuroimage Clin; 2022; 36():103165. PubMed ID: 36037662
[TBL] [Abstract][Full Text] [Related]
35. The consequence of cerebral small vessel disease: Linking brain atrophy to motor impairment in the elderly.
Su N; Liang X; Zhai FF; Zhou LX; Ni J; Yao M; Tian F; Zhang SY; Jin ZY; Cui LY; Gong G; Zhu YC
Hum Brain Mapp; 2018 Nov; 39(11):4452-4461. PubMed ID: 29956412
[TBL] [Abstract][Full Text] [Related]
36. 25-Hydroxy vitamin D level is associated with total MRI burden of cerebral small vessel disease in ischemic stroke patients.
Feng C; Tang N; Huang H; Zhang G; Qi X; Shi F
Int J Neurosci; 2019 Jan; 129(1):49-54. PubMed ID: 30033803
[TBL] [Abstract][Full Text] [Related]
37. l-Arginine Pathway Metabolites Predict Need for Intra-operative Shunt During Carotid Endarterectomy.
Szabo P; Lantos J; Nagy L; Keki S; Volgyi E; Menyhei G; Illes Z; Molnar T
Eur J Vasc Endovasc Surg; 2016 Dec; 52(6):721-728. PubMed ID: 27839876
[TBL] [Abstract][Full Text] [Related]
38. Associations between left ventricular function, vascular function and measures of cerebral small vessel disease: a cross-sectional magnetic resonance imaging study of the UK Biobank.
van Hout MJP; Dekkers IA; Westenberg JJM; Schalij MJ; Scholte AJHA; Lamb HJ
Eur Radiol; 2021 Jul; 31(7):5068-5076. PubMed ID: 33409793
[TBL] [Abstract][Full Text] [Related]
39. Hypertensive Exposure Markers by MRI in Relation to Cerebral Small Vessel Disease and Cognitive Impairment.
Amier RP; Marcks N; Hooghiemstra AM; Nijveldt R; van Buchem MA; de Roos A; Biessels GJ; Kappelle LJ; van Oostenbrugge RJ; van der Geest RJ; Bots ML; Greving JP; Niessen WJ; van Osch MJP; de Bresser J; van de Ven PM; van der Flier WM; Brunner-La Rocca HP; van Rossum AC;
JACC Cardiovasc Imaging; 2021 Jan; 14(1):176-185. PubMed ID: 33011127
[TBL] [Abstract][Full Text] [Related]
40. Tracer kinetic assessment of blood-brain barrier leakage and blood volume in cerebral small vessel disease: Associations with disease burden and vascular risk factors.
Stringer MS; Heye AK; Armitage PA; Chappell F; Valdés Hernández MDC; Makin SDJ; Sakka E; Thrippleton MJ; Wardlaw JM
Neuroimage Clin; 2021; 32():102883. PubMed ID: 34911189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
